Does RAVULIZUMAB-CWVZ Cause Haemoglobin decreased? 346 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 346 reports of Haemoglobin decreased have been filed in association with RAVULIZUMAB-CWVZ. This represents 3.4% of all adverse event reports for RAVULIZUMAB-CWVZ.
346
Reports of Haemoglobin decreased with RAVULIZUMAB-CWVZ
3.4%
of all RAVULIZUMAB-CWVZ reports
6
Deaths
70
Hospitalizations
How Dangerous Is Haemoglobin decreased From RAVULIZUMAB-CWVZ?
Of the 346 reports, 6 (1.7%) resulted in death, 70 (20.2%) required hospitalization, and 3 (0.9%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 346 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Myasthenia gravis (338)
Back pain (326)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Haemoglobin decreased Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST